More Articles

Cipla enters the biosimilars market Biosimilars/News | Posted 02/07/2010

India-based generics’ manufacturer Cipla is paying US$65 million to buy a significant minority stake in two Asian biotech companies with plans to develop a range of discounted biosimilars, generic...

Astra Zeneca losing generic esomeprazole battle Generics/News | Posted 02/07/2010

On 17 June 2010, AstraZeneca announced that its efforts in Canada to stop the launch of a generic version of its patented, stomach-acid-relief drug Nexium (esomeprazole), were rejected by the Canad...

Bayer sues Teva over generic Yaz contraceptive Generics/News | Posted 02/07/2010

On 15 June 2010, German-based Bayer Schering Pharma (Bayer) announced that it was suing the Israeli generic giant, Teva Pharmaceuticals (Teva), for false advertising and patent infringement in conn...

Sanofi-aventis and Nichi-Iko announce joint venture for generics in Japan Pharma News | Posted 02/07/2010

Sanofi-aventis and Nichi-Iko Pharmaceutical Co., Ltd. (Nichi-Iko) have announced that they have signed an agreement to establish a new joint venture, called sanofi-aventis Nichi-Iko KK, in order to...

FDA creates new division to speed up generic approval times Generics/General | Posted 25/06/2010

As the FDA’s Office of Generic Drugs (OGD) struggles to keep up with its growing backlog of abbreviated new drug approvals (ANDAs), the office is creating a new chemistry division that it hopes wil...

Hospira’s biosimilar filgrastim product Nivestim approved Biosimilars/News | Posted 25/06/2010

On 10 June 2010, Hospira received approval from the European Commission for its biosimilar filgrastim product, Nivestim, for the prevention of febrile neutropenia and reduction in duration of chemo...

Orchid acquires US generic sales and marketing company Karalex Pharma News | Posted 25/06/2010

On 10 June 2010, Indian-based generics manufacturer, Orchid Chemicals & Pharmaceuticals (Orchid) announced that it had entered into an agreement to acquire Karalex Pharma, LLC, a US-based gener...

Ranbaxy launches generic antiplatelet agent Prasita in India Generics/News | Posted 25/06/2010

On 10 June 2010, Indian-based Ranbaxy Laboratories Limited (Ranbaxy) announced the launch of a generic version of Prasugrel in India. The product, called Prasita, is an antiplatelet agent for the p...